Rac1, a member of the small Rho GTPase family, plays multiple cellular roles. Studies of mice conditionally lacking Rac1 have revealed essential roles for Rac1 in various tissues, including cartilage and limb mesenchyme, where Rac1 loss produces dwarfism and long bone shortening. To gain further insight into the role of Rac1 in skeletal development, we have used transgenic mouse lines to express a constitutively active (ca) Rac1 mutant protein in a Cre recombinase-dependent manner. Overexpression of caRac1 in limb bud mesenchyme or chondrocytes leads to reduced body weight and shorter bones compared with control mice. Histological analysis of growth plates showed that caRac1; Col2-Cre mice displayed ectopic hypertrophic chondrocytes in the proliferative zone and enlarged hypertrophic zones. These mice also displayed a reduced proportion of proliferating cell nuclear antigen-positive cells in the proliferative zone and nuclear b-catenin localization in the ectopic hypertrophic chondrocytes. Importantly, overexpression of caRac1 partially rescued the phenotypes of ;Prx1-Cre conditional knockout mice, including body weight, bone length, and growth plate disorganization. These results suggest that tight regulation of Rac1 activity is necessary for normal cartilage development. (Endocrinology 158: 3386-3398, 2017) 
M
ost bones of the skeleton develop through endochondral ossification, whereby mesenchymal cells first condense at the sites of future bones (1), differentiate into chondrocytes, and mature stepwise toward hypertrophy while secreting cartilage-specific extracellular matrix (ECM). Mesenchymal cells undergoing chondrogenesis become distinctly spherical as they initiate the expression of the transcription factors Sox9 (2), Sox5, and Sox6, which promote expression of genes encoding the ECM constituents type II collagen (Col2a1) and aggrecan (Acan) (3) (4) (5) . The developing growth plate is highly organized and divided into distinctive regions, with chondrocytes progressing from the resting/reserve zone to the proliferative zone before undergoing terminal differentiation and massive cellular enlargement in the hypertrophic zone. Hypertrophic chondrocytes mineralize their surrounding matrix, secrete matrix metalloproteases to degrade the ECM, and produce vascular endothelial growth factor to induce vascularization and promote ossification (6) (7) (8) . Through these processes, opposing cartilage growth plates located at either end of the bone anlagen control longitudinal growth during embryonic and postnatal development (9) .
Rho family GTPases, including Rac, RhoA, and Cdc42, are inactive when bound to guanosine diphosphate (GDP) but become activated by exchanging GDP for guanosine triphosphate (GTP) in response to a variety of extracellular stimuli during diverse cellular functions, including cell migration, proliferation, and apoptosis. Three Rac genes share high sequence similarity: Rac1 is ubiquitously expressed, Rac2 is most strongly expressed in cells of hematopoietic origin (10, 11) , and Rac3 is most abundant in the brain (12) (13) (14) .
Previous in vitro reports demonstrate that Rac1 and other Rho family members promote chondrogenesis. For example, transfection of Rac1 or Cdc42 into primary chondrocytes enhances Col10a1 promoter activity (15) . Furthermore, overexpression of Rac1 in chondrogenic ATDC5 cells inhibited proliferation; accelerated apoptosis; increased expression of Sox9, Sox5, Sox6, Col2a1, and Acan; and activated the p38 MAP kinase pathway (15, 16) . Conversely, inhibition of p38 signaling blocked the effects of Rac1 and Cdc42 overexpression, including Col10a1 promoter activation and apoptosis (15) , whereas pharmacological inhibition of Rac1 in micromass cultures resulted in reduced chondrocyte gene expression and decreased glycosaminoglycan accumulation (16) .
Mice completely lacking Rac1 are embryonic lethal and show a range of defects in germ-layer formation (17) , making the use of tissue-specific knockout [conditional knockout (cKO)] mice critical in the study of Rac1 function during development. Cartilage-specific (Col2a1 promoter) inactivation of Rac1 produced skeletal deformities, severe kyphosis, and dwarfism (18, 19) . Rac1-deficient growth plates were disorganized and hypocellular, with chondrocytes of abnormal shape and size, and displayed reduced proliferation, reduced p38 MAP kinase phosphorylation, increased apoptosis, and deregulated expression of Ihh, Ccnd1 (cyclin D1), and Cdkn1 (p57). Prx1-Cre-mediated inactivation of Rac1 in limb mesenchyme prior to chondrogenesis led to long bone shortening that was comparable to that observed in Col2-Cre Rac1 cKO mice (20) . However, the mechanisms by which this occurs are unclear. These in vivo data suggest that Rac1 plays important roles during chondrogenesis.
Although these studies suggest that Rac1 is essential for normal cartilage development, another recent study suggests that activation of Rac1 contributes to cartilage breakdown in osteoarthritis (21) . Given the close links between cartilage development and osteoarthritis [reviewed in Pitsillides and Beier (22)], we therefore asked whether increased Rac1 signaling would also affect skeletal growth and development. Based on our results and on these published studies (15, 23, 24) , we expected premature chondrocyte hypertrophy upon ectopic activation of Rac1 in growth plate chondrocytes.
Site-directed mutagenesis altering the amino acid sequence in the GDP/GTP binding and GTPase-activating regions of small GTPases has been used to study the functions of Rho GTPases. For example, glycine-12 to valine (G12V) Rac1 mutants are unable to hydrolyze GTP and exhibit a constitutively active (ca) phenotype. Overexpression of caRac1;G12V has been shown to induce chondrocyte hypertrophy and to increase matrix metalloprotease gene expression in vitro, which are characteristics of mature chondrocytes (23) .
To elucidate the tissue-specific and/or developmental stage-specific roles of Rac1 in vivo, we crossed ROSA-STOP floxed -Rac1
G12V
-IRES-EGFP mice with mice carrying either Col2-Cre or Prx1-Cre to overexpress Rac1 G12V in skeletal tissue. By analyses of these mice, we expected to establish whether Rac1 activation is essential for cartilage development and especially for maturation of chondrocytes. We report several phenotypes in mice conditionally overexpressing constitutively active (ca) Rac1, including cartilage and chondrocyte abnormalities. Furthermore, we show that caRac1 overexpression can partially rescue the skeletal defects in Prx1-Cre and Col2-Cre Rac1 cKO mice.
Materials and Methods

Antibodies
The following antibodies were used in this study: Rac1 
Animals
Mice were exposed to a 12-hour light-dark cycle, given tap water, and fed regular chow ad libitum. All procedures involving animals were approved by the University of Western Ontario Animal Care and Use Committee. For embryonic time points, noon on the day after mating was considered to be embryonic day (E)0.5. Mice older than postnatal day (P)10 were compared within sex. The work was performed on both male and female mice.
Mice conditionally overexpressing constitutively active Rac1 were generated by mating ROSA-STOP floxed -Rac1 G12V -IRES-EGFP mice with the C57BL/6 background to Col2-Cre or Prx1-Cre Tg mice (Fig. 1A) (25) (26) (27) . A STOP transcription terminator cassette flanked by two loxP sites blocked expression of HA-tagged Rac1 G12V and enhanced green fluorescent protein (EGFP) in Cre-negative tissue (Fig. 1A) . Expression of Cre recombinase leads to the excision of the floxed STOP cassette, resulting in the expression of Rac1 G12V and EGFP. ROSA-STOP floxed -Rac1 G12V -IRES-EGFP mice (C57BL/6-Gt(ROSA)26Sor tm9(Rac1*,EGFP)Rsky /J, stock number: 012361) were obtained from Jackson Laboratories (Bar Harbor, ME). Rac1 cKO mice were generated by mating Rac1 flox mice (28) with Prx1-Cre (27) or Col2-Cre mice (26) . Genotyping primers are shown in Supplemental Table 2A .
Quantitative reverse transcription polymerase chain reaction
Total RNA was extracted from long bone cartilage at E15.5 or limb buds at E12.5 using TRIzol (Life Technologies, Carlsbad, CA) and then reverse-transcribed using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Quantitative realtime polymerase chain reaction (PCR) was performed using iQ SYBR Green Supermix (Bio-Rad) and the CFX384 reverse transcription PCR (RT-PCR) system (Bio-Rad). Primer sequences are in Supplemental Table 2B . Expression was normalized to Actb.
Western blot analysis E15.5 long bone cartilage, newborn calvariae, or E12.5 limb buds were dissected in phosphate-buffered saline, homogenized in radioimmunoprecipitation assay buffer using a fine-gauge needle, and then quantified using the BCA Protein Assay Kit (Thermo Fisher, Waltham, MA). Sodium dodecyl sulfate polyacrylamide gel electrophoresis sample buffer was added to protein samples (20 to 30 mg), followed by boiling for 5 minutes. Samples were loaded into precast gradient Mini-PROTEAN TGX Gels (Bio-Rad) and were then separated and transferred to Immun-Blot PVDF Membrane (Bio-Rad) using the Mini Trans-Blot Cell system (Bio-Rad). Membranes were blocked in Tris-buffered saline-Tween 20 containing 5% bovine serum albumin, incubated with primary antibodies according to the supplier's instructions, and then incubated with appropriate horseradish peroxidase-conjugated secondary antibodies before signal detection with SuperSignal West Substrate (Thermo Fisher) using a ChemiDoc MP Imaging system (Bio-Rad). Blots representative of at least three independent experiments are shown.
Skeletal staining
Skeletons were stained as previously described (18, 20) . Images were captured with a Leica S6 D stereomicroscope and a Leica EC3 camera using Leica Application Suite software (Leica, Wetzlar, Germany). Representative images from at least three independent littermate pairs are shown.
Histology and safranin-O/fast green staining
Freshly dissected bones were fixed overnight in 4% paraformaldehyde and decalcified as required in 5% EDTA solution before processing and embedding in paraffin wax. Sections were prepared by the Molecular Pathology Laboratory at the Robarts Research Institute (London, ON, Canada).
Sections (4 mm) were stained as previously described (29, 30) . Images were captured with a Leica DM1000 microscope and Leica DFC295 camera using Leica Application Suite software. Images representative of at least three independent littermate pairs are shown.
Immunohistochemistry
Sections (4 mm) were stained as previously described (18, 29) . Representative images from at least three independent littermate pairs are shown. 
Terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling analysis
Samples were sectioned and processed as described earlier. Analysis of apoptotic chondrocytes was performed using the DNA Fragmentation Detection Kit [terminal deoxynucleotidyltransferasemediated dUTP nick end labeling (TUNEL)] (Millipore) on tibia sections (4 mm) according to the manufacturer's instructions.
In situ hybridization
Digoxigenin-labeled RNA probes were made using T3 or T7 RNA polymerases (Roche) and Col2a1 or Col10a1 (a gift from Dr. S. Takeda) plasmid DNA (31), which were cut using appropriate restriction enzymes, with incubation for 5 hours at 37°C.
Samples were sectioned and processed as described previously. Sections (4 mm) were incubated with 1 mg/mL proteinase K for 10 minutes at room temperature, acetylated in 0.1 M triethanolamine (pH 8.0) for 20 minutes at room temperature, hybridized with probe for 16 hours at 42°C, incubated with 20 mg/mL RNase A for 30 minutes at 37°C, blocked with 1% Blocking Reagent (Roche) for 30 minutes at room temperature, and incubated with Anti-Digoxigenin-AP antibodies for 1 hour at room temperature. For detection, sections were incubated with 4-nitro blue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl-phosphate substrate solutions for the appropriate time, counterstained with 0.5% methyl green, and mounted. Representative images from at least three independent littermate pairs are shown.
Statistical analysis
The results are expressed as the mean 6 SD for each experiment. Student's two-tailed t test was used, with P , 0.05 considered significant.
Results
Overexpression of caRac1 in cartilage and limb bud mesenchyme
Mice carrying the unrecombined STOP transcription terminator cassette inserted into the ROSA locus (e.g., before Cre-mediated recombination) are referred to as control mice (Fig. 1A) . We verified expression of the
G12V -IRES-EGFP mice after crossing them to mice carrying either Col2-Cre or Prx1-Cre. Mice were represented as Col2-caRac1 Single (hemizygous; one copy of floxed allele) or Double (homozygous: two copies of floxed allele) and Prx1-caRac1 Single or Double. Quantitative RT-PCR using RNA extracted from E15.5 long bone cartilage or E12.5 limb buds revealed significantly increased expression of Rac1 in Col2-caRac1 Double and Prx1-caRac1 Double mice ( Fig. 1B ; primers recognize both endogenous wild type Rac1 and transgenic caRac1). Western blot analysis showed that 3x HA-tagged Rac1 G12V protein (24.5 kDa) and GFP were expressed in E15.5 long bone cartilage from Col2-caRac1 Single and Col2-caRac1 Double mice and in E12.5 limb buds from Prx1-caRac1
Single and Prx1-caRac1 Double mice but not in mice lacking Cre expression (Fig. 1C ). Western blotting with antibodies to HA demonstrated that caRac1 abundance in long bones and limb buds of homozygous mutants was 1.6-to 2.3-fold higher compared with hemizygous mutants, whereas these proteins were hardly detectable in newborn calvariae of Col2-caRac1 Single or Col2-caRac1 Double mice, as expected (Fig. 1C ). Antibodies to Rac1 detected endogenous Rac1 protein (21 kDa) at normal levels in transgenic samples but only weakly detected the larger (24.5 kDa) 3x HA-tagged exogenous Rac1
G12V . These data demonstrate that conditional caRac1 was expressed in a Cre-dependent manner.
caRac1 overexpression results in reduced body weight and shorter bones Col2-caRac1 Single, Col2-caRac1 Double, Prx1-caRac1 Single, and Prx1-caRac1 Double mice were born at the expected Mendelian ratios, lived at least to breeding age, and displayed no obvious phenotypes (data not shown; Supplemental Fig. 1A and 1C , left panels). However, Col2-caRac1 Double and Prx1-caRac1 Double mice weighed slightly but significantly less at P10 and P21 compared with control mice, whereas Col2-caRac1 Single mice were significantly underweight at P10 (Supplemental Fig. 1A and 1C , right panels). Tibiae were significantly shorter in all caRac1-overexpressing mice at P10 and P21, except in Prx1-caRac1 Single mice at P21 (Supplemental Fig. 2B and 2D ). There was a similar trend in mutant femora and humeri (data not shown).
Prx1-Rac1 cKO (Rac1 fl/fl ;Prx1-Cre) mice display syndactyly and brachydactyly, especially in the forelimbs (Supplemental Figs. 9C and 11A) (20) . However, the limbs and phalanges of Prx1-caRac1 Single and Prx1-caRac1 Double mice were normal (Supplemental Fig. 2A and 2B). Furthermore, whereas Prx1-Rac1 cKO mice displayed incomplete sternal fusion (Supplemental Fig. 9D ) (20) , sternal morphology was normal in Prx1-caRac1 Single and Prx1-caRac1 Double mice (Supplemental Fig. 2C ). These data suggest that overexpression of caRac1 in cartilage or limb bud mesenchyme impairs bone growth and leads to reduced body weight but does not affect skeletal patterning.
caRac1 overexpression results in disorganized growth plates
Histological analysis of mutant tibia sections did not reveal any distinctive changes in the growth plates at P1 (Supplemental Fig. 3A and 3B, upper panels), an age at which mutant body weight was normal (data not shown). However, total growth plate and combined resting zone plus proliferative zone lengths were shorter in Col2-caRac1 Double mice, whereas the hypertrophic zone was significantly enlarged in Prx1-caRac1 Double mice (Supplemental Fig. 3A and 3B , lower panels).
At P10, shortened total growth plate lengths and hypertrophic zones were observed in Col2-caRac1 Single and Col2-caRac1 Double mice ( Fig. 2A, lower panel) , and secondary ossification was delayed in the majority (5/8) of Col2-caRac1 Double mice ( Fig. 2A, upper panels) . Additionally, Col2-Cre mice hemi-or homozygous for caRac1 displayed disorganized columnar structure in the proliferative zone, which included the formation of chondrocyte clusters and ectopic hypertrophic chondrocytes. The length of the proliferative zone in Col2-caRac1 Double mice was significantly reduced (Fig. 2A, lower panel) .
Interestingly, these growth plate phenotypes changed at P21. Rather than forming regular columns, chondrocytes in the proliferative zone formed clusters in Col2-caRac1 Single and Col2-caRac1 Double mice (Fig. 2B , upper panels, magnifications), although proliferative zone length was similar to control mice (Fig. 2B , left graph in lower panel). The hypertrophic zones in Col2-caRac1 Double mice were significantly enlarged (Fig. 2B, lower panel) , and although the number of cells in each hypertrophic column was comparable to control mice (data not shown), the cells were larger (Fig. 2B, right graph in lower panel) .
At P10, Prx1-Cre mice hemi-or homozygous for caRac1 had enlarged hypertrophic zones (Fig. 3A, lower panel) and displayed disorganized proliferative zone columnar structure, although this defect was mild compared with Col2-caRac1 Single or Col2-caRac1 Double mice (Fig. 3A, upper panels) . The disorganized columnar structure of the proliferative zone in Prx1-caRac1 Double mice persisted to P21 (Fig. 3B, upper panels) , but neither zone length was significantly different from control mice at this age (Fig. 3B, lower panel) .
At P42, proliferative and hypertrophic zone lengths in Col2-caRac1 Double mice were similar to control mice (Supplemental Fig. 4B, lower panels) , although mutant mice displayed reduced body weight, bone length (Supplemental Fig. 4A ), and disorganized columnar structure (Supplemental Fig. 4B, upper panels) . Taken together, these results suggest that caRac1 overexpression differentially affects cartilage formation in growth plates depending on the developmental stage.
Distribution of caRac1 is different in each zone of the growth plate
To investigate the basis of the phenotypic differences between Col2-Cre and Prx1-Cre caRac1-overexpressing mice, we analyzed the distribution patterns of caRac1 in the growth plate. HA-tagged caRac1 was detected using immunohistochemical staining at P10 in the growth plates of both Col2-Cre and Prx1-Cre mutants, whereas caRac1 was completely undetectable in control mice, as expected ( Fig. 4A and 4B ). caRac1 staining in homozygous mutants was stronger than in hemizygous mutants, which is consistent with Western blot data (Fig. 1C) . High magnification images revealed that caRac1 is strongly expressed in the proliferative and hypertrophic zones and that caRac1 expression increases along a gradient from the proliferative to the hypertrophic zone. Interestingly, caRac1 was weakly expressed in the resting zone of Prx1-caRac1 Double mice at P10. Immunohistochemical detection of GFP, which is expressed from the same locus through an internal ribosomal entry site, showed a similar pattern and confirms the near complete absence of expression in the resting zone in Prx1-caRac1 Double mice ( Fig. 4C; Supplemental Fig. 5 ). Remarkably, the majority of chondrocytes in the resting zone of Col2-caRac1 Double and Prx1-caRac1 Double mice are HA positive at P1 (Fig. 4D) . Strong staining was seen in trabecular bone with both Cre driver lines, consistent with the known activity of the Prx1 promoter (27) and recent data on Col2-Cre-driven recombination in bone cells (32) .
caRac1 overexpression in cartilage results in reduced chondrocyte proliferation
Because the length of growth plates in caRac1-overexpressing mice was altered, we chose to examine chondrocyte proliferation and apoptosis. The proportion of proliferating PCNA-positive cells in the proliferative zone was reduced by approximately 10% in Col2-caRac1 Double mice at P10 but was similar to control mice at P21 (Fig. 5A) . Additionally, the number of apoptotic (TUNELpositive), terminally differentiated hypertrophic chondrocytes at the interface between the hypertrophic zone and trabecular bone was not significantly different between Col2-caRac1 Double mice and control mice at P10 or P21 (Fig. 5B) . Conversely, the proportions of proliferating and apoptotic cells were normal in Prx1-caRac1 Double mice at P10 (Supplemental Fig. 6 ). These results reveal a transient reduction in chondrocyte proliferation with normal apoptosis in Col2-caRac1 Double mice, whereas neither proliferation nor apoptosis was altered in Prx1-caRac1 Double mouse growth plates.
caRac1 overexpression does not affect chondrocyte differentiation
Next, we examined the expression patterns and levels of genes associated with chondrocyte development in caRac1-overexpressing mice. In situ hybridization revealed that Col2a1 and Col10a1 expression patterns were similar in control and Col2-caRac1 Double mice at both P10 and P21 (data not shown). Ectopic hypertrophic chondrocytes in the proliferative zone of Col2-caRac1 Double mice expressed Col2a1 but not Col10a1, demonstrating that these cells preserve aspects of normal gene expression with respect to their position in the growth plate. Quantitative RT-PCR using RNA extracted from E15.5 long bone cartilage revealed that expression levels of Sox9, Col2a1, and Col10a1 in Col2-caRac1 Double mice were not significantly different from control mice (data not shown). These results suggest that chondrocyte gene expression remains largely unaffected by caRac1 overexpression in growth plates.
b-Catenin localization and p38 activity in
Col2-caRac1 Double mice
Because caRac1 was previously reported to enhance b-catenin nuclear localization (33), we examined b-catenin distribution in caRac1-overexpressing chondrocytes. Speckled b-catenin was observed mainly in the cytosol of proliferating zone cells, whereas nuclear b-catenin was observed in prehypertrophic zone cells in control animals. Nuclear b-catenin was also observed in ectopic hypertrophic chondrocytes in Col2-caRac1 Double mice at P10 and P21 (data not shown). Otherwise, the distribution of b-catenin in Col2-caRac1 Double and Prx1-caRac1 Double mice was similar to control mice, as was the total amount of b-catenin (data not shown), consistent with the previous report (33) . This suggests that caRac1 may enhance nuclear b-catenin localization in prematurely hypertrophying chondrocytes in the proliferating zone.
Because Col2-Rac1 cKO (Rac1 fl/fl ;Col2-Cre) mice displayed reduced phosphorylation of p38 MAP kinase (18), we examined phosphorylation of p38 in caRac1-overexpressing mice. Western blot analysis of E15.5 long bone cartilage and E12.5 limb buds indicated that levels of phosphorylated p38 in caRac1-overexpressing mice were similar to control mice, which was also the case in P0 calvariae (Supplemental Fig. 7 ). These data suggest that caRac1 overexpression did not alter phosphorylation of p38.
caRac1 overexpression partially rescued Col2-Rac1 and Prx1-Rac1 cKO mouse phenotypes
To investigate whether caRac1 can compensate for endogenous Rac1 loss during cartilage and skeletal development, we generated mice conditionally overexpressing caRac1 in a Rac1-null background by crossing ROSA-STOP floxed -Rac1
G12V
-IRES-EGFP mice to Col2-Rac1 and Prx1-Rac1 cKO mice. Western blot analysis showed that HA-tagged caRac1 (24.5 kDa) and GFP were expressed in E15.5 long bone cartilage from Col2-Rac1 cKO mice overexpressing caRac1 in a hemi-or homozygous state and in E12.5 limb buds from Prx1-Rac1 cKO mice overexpressing caRac1 in a hemi-or homozygous state (Supplemental Figs. 8A and 9A ). caRac1 abundance was 2.2 and 2.9 times higher in Col2-Rac1 cKO; caRac1 Double and Prx1-Rac1 cKO; caRac1 Double mice than in Col2-Rac1 cKO; caRac1 Single and Prx1-Rac1 cKO; caRac1 Single mice, respectively. Antibodies to Rac1 detected endogenous Rac1 (21 kDa), which was reduced 70% to 85% in tissue from all Cre-positive Rac1 fl/fl mice regardless of caRac1 hemi-or homozygosity. Moreover, we detected HA-tagged caRac1 (24.5 kDa) in all caRac1-overexpressing mice using these antibodies. It appeared that exogenous caRac1 could be detected more easily using the antibodies to Rac1 when endogenous Rac1 was reduced in cKO mice.
Col2-Rac1 and Prx1-Rac1 cKO mice display dwarfism (18, 20) (Supplemental Figs. 8A and 9A , left panels). Mice overexpressing caRac1 in the hemi-or homozygous state in either the Col2-Rac1 or Prx1-Rac1 cKO genetic backgrounds were significantly heavier than mice lacking exogenous caRac1 (Supplemental Figs. 8A and 9A, right panels). However, mice overexpressing caRac1 were lighter than control mice. Notably, the introduction of caRac1 in either the hemi-or homozygous state partially rescued tibia shortening in Rac1 fl/fl ;Col2-Cre or Prx1-Rac1 cKO genetic backgrounds at P21 (Supplemental Figs. 8C and 9E ).
Histological analysis of tibia mesial growth plates revealed that those in Col2-mice had a longer proliferative zone, disorganized columnar structure, and delayed secondary ossification at P21 (Supplemental Fig. 8D, left panels) . The proliferative zone was significantly shorter in Col2-Rac1 cKO; caRac1 Single and Col2-Rac1 cKO; caRac1 Double mice compared with Col2-Rac1 cKO mice, although this rescue was incomplete (Supplemental Fig. 8D, left and right panels) . Furthermore, the disorganization of columnar structure and delay of secondary ossification in Col2-Rac1 cKO; caRac1 Single and Col2-Rac1 cKO; caRac1 Double growth plates were mild compared with Col2-Rac1 cKO mice. Col2-Rac1 cKO; caRac1 Single and Col2-Rac1 cKO; caRac1 Double mice displayed similar levels of rescue (Supplemental Fig. 8D , left panels; Supplemental Fig. 10) .
Because Prx1-Rac1 cKO mice displayed syndactyly and brachydactyly (20) , we examined the limbs of Prx1-Rac1 cKO; caRac1 Single and Prx1-Rac1 cKO; caRac1 Double mice. Although syndactyly was not rescued (Supplemental Fig. 11A ), the dramatic shortening of the middle phalanges in Prx1-Rac1 cKO mice was partially rescued in Prx1-Rac1 cKO; caRac1 Single mice (Supplemental Fig. 9C ). Additionally, whereas the sternums of Prx1-Rac1 cKO mice were completely separated, the rostral part of the sternum is closed in Prx1-Rac1 cKO; caRac1 Single mice, presenting an intermediate phenotype ( Supplemental Fig. 9D) .
The hypertrophic zones in Prx1-Rac1 cKO mice were enlarged and the columnar structure was disorganized (Supplemental Fig. 9F, left panels) , a defect that was mitigated by hemi-or homozygous caRac1 overexpression ( Supplemental Fig. 9F, left and right panels) . Thus, although the disorganization of columnar structures in Prx1-Rac1 cKO; caRac1 Single and Prx1-Rac1 cKO; caRac1 Double growth plates was much milder than in Prx1-Rac1 cKO mice, both hemi-and homozygous caRac1 overexpression led to some disorganization on the Prx1-Rac1 cKO background (Supplemental Fig. 9F, right panels; Supplemental Fig. 11B ). These results suggest that exogenous caRac1 can partially overcome the effects of deleting endogenous Rac1 during cartilage and skeletal development.
Discussion
Although previous studies demonstrated that deletion of Rac1 in cartilage or limb bud mesenchyme leads to dwarfism (18, 20) , the biological functions of activated Rac1 during cartilage development were largely unknown. To investigate this question, we generated mice overexpressing caRac1 in cartilage-and limb bud mesenchyme-specific manners. Here, we report insights regarding the key roles of activated Rac1 during cartilage development. Our data show that Rac1 activation leads to growth plate defects that partially resemble those of mice with reduced Rac1 levels in cartilage. These data strongly demonstrate that both overactivation and inhibition of Rac1 in cartilage lead to pathological effects, suggesting that tight regulation of Rac1 signaling is crucial for normal skeletal development. Rac1 activity is highly regulated by multiple upstream signals (including integrin and growth factor receptors) and couples to multiple downstream effector pathways (34) . As a central node in cellular signaling pathways, it has to be highly regulated, and any major change from its physiological activity is likely to cause some abnormalities. We were surprised that the phenotypes observed upon either deletion or overactivation of Rac1 appear similar in some aspects (but clearly different in others). However, the primary effect in either scenario appears to be the disorganization of the growth plate, potentially due to altered cell-matrix and/or cell-cell interactions. It is feasible to speculate that both suppression and increase of Rac1 activity alter these interactions, leading to changes in columnar architecture. These then secondarily affect growth plate dynamics and bone growth. Nevertheless, there are also clear differences between our knockout and overexpression models, such as the absence of effects of caRAc1 on apoptosis and the milder and more transient nature of the phenotypes in our overexpressing mice.
caRac1-overexpressing mice displayed growth plate disorganization, which likely led to shorter bone lengths and reduced body weight. Comparison of P21 growth plates from various genotypes revealed a variety of defects differing in severity (Fig. 6 ). Col2-Rac1 cKO mice have an enlarged proliferative zone with disorganized columnar structure and rounded cells, whereas Prx1-Rac1 cKO mice have an enlarged hypertrophic zone due to more cells. In contrast, Col2-Cre caRac1 mice have enlarged hypertrophic chondrocytes and ectopic hypertrophy in the proliferative zone, whereas Prx1-Cre caRac1 mice display mildly disorganized columnar structures. These differences between Col2-Cre and Prx1-Cre growth plate disorganization might depend on the timing and pattern of Cre expression. However, the lengths of the growth plates in Rac1 cKO mice overexpressing caRac1 via either Col2-Cre or Prx1-Cre are similar to control mice, although the columnar structure remains disorganized. This finding suggests that caRac1 partially compensates for the loss of endogenous Rac1.
Western blot analysis revealed that caRac1 and EGFP were expressed specifically in tissues where Cre recombination was expected. Furthermore, homozygous caRac1 overexpression led to 1.6-to 2.3-fold higher caRac1 abundance compared with levels in hemizygous mutants, with immunohistochemical analysis showing a similar trend. Differences in the abundance of caRac1 are the likely explanation why homozygous mutants have Goat; polyclonal more severe phenotypes, including differences in body weight, bone length, and growth plate disorganization. Col2-Cre and Prx1-Cre caRac1-overexpressing mice displayed different growth plate defects, which is likely due to different spatial and temporal patterns of Cre-mediated recombination. In Col2-Cre-overexpressing caRac1 mice, resting, proliferative, and hypertrophic zones were shorter at P1 and P10, and the hypertrophic zone was longer at P21 due to increased cell size. Over time, these differences resolve, and all mutant growth plate zones were similar to control mice at P42. The decreased population of PCNA-positive cells in the mutant proliferative zone at P10 may have caused shortening of this zone, which is consistent with previous in vitro data reporting that proliferation of ATDC5 cells was reduced In contrast to Col2-Cre overexpressing caRac1 mice, Prx1-Cre caRac1-overexpressing mice displayed an enlarged hypertrophic zone at P1 and P10, which disappeared by P21. caRac1 and GFP expression patterns differed slightly between Col2-Cre-and Prx1-Cre caRac1-overexpressing mice, which may contribute to the differences in growth plate disorganization between these mice. The most conceivable explanation is that Prx1-Cre is expressed earlier in development and more widely in limb tissues than Col2-Cre (26, 27) . Thus, the early effects of caRac1 overexpression in cartilage may contribute to long-term phenotypes, including reduced body weight and shortened bone length, even though the growth plate disorganization becomes milder with age.
A previous report showed that caRac1 enhanced nuclear localization of b-catenin (33). Consistent with this report, we detected nuclear b-catenin in ectopic hypertrophic chondrocytes in Col2-caRac1 Double mice. Mice overexpressing constitutively active b-catenin in cartilage had growth plates that were phenotypically similar to those in Col2-caRac1 Double mice and displayed a lengthened hypertrophic zone, shorter hypertrophic zone-to-epiphysis distance, and disorganized columnar structure with cluster formation in the hypertrophic zone (35) . These data suggest that Rac1 activation controls nuclear localization of b-catenin and, therefore, chondrocyte hypertrophy. However, the growth plate defects appeared earlier and were more severe in constitutively active b-catenin-overexpressing mice compared with caRac1-overexpressing mice. Conversely, pharmacological inhibition of glycogen synthase kinase 3 signaling in tibia organ cultures results in more abundant b-catenin in the prehypertrophic zone, increased proliferation in the proliferative zone, and enhanced bone growth (29) . These results suggest that b-catenin's role in cartilage development is spatiotemporally regulated in a complex manner by various factors, including Rac1 and glycogen synthase kinase 3. Additional studies are needed to further clarify the interaction between Rac1 activation and Wnt/b-catenin signaling in chondrogenesis, for example, by crossing Col2-Rac1 or Prx1-Rac1 cKO mice with constitutively active b-cateninoverexpressing mice. Constitutively active b-catenin overexpression might rescue phenotypes of Rac1 cKO mice in cartilage.
caRac1 transfection into chondrocytes enhances Col10a1 promoter activity and expression of Mmp7, Mmp9, and Mmp13 (15, 23) , suggesting that caRac1 can accelerate chondrocyte maturation. Whereas the expression patterns of Col2a1 and Col10a1 in Col2-caRac1 Double growth plates were similar to control mice, mutants displayed enlarged hypertrophic chondrocytes in the hypertrophic zone and ectopic hypertrophic chondrocytes in the proliferative zone, indicating that caRac1 promotes cell enlargement independent of chondrocyte differentiation. This discrepancy implies that differences between in vitro and in vivo conditions may influence Rac1 function. For example, a two-dimensional cell culture system does not adequately model three-dimensional growth plate organization, which includes tightly regulated cell-ECM interactions. Moreover, extracellular stimulation of Rac1 via serum in media does not fully recapitulate the normal biological growth factors found in developing growth plates.
Several other cartilage-specific cKO mice, such as integrinlinked kinase (Ilk) mutant mice, have growth plate phenotypes similar to Rac1 cKO mice (26) . Downregulation of Ilk by small interfering RNA reduces the abundance of activated Rac1, whereas Ilk overexpression actives Rac1 (36, 37) . Additionally, fibroblasts from Ilk fl/fl ;Col1a2-Cre mice display reduced Rac1 activation (38, 39) . It is therefore possible that overexpression of caRac1 might rescue the growth plate phenotypes of Ilk cKO mice. Demonstrating this rescue would support a model whereby Ilk normally activates Rac1 and that Rac1 is the major downstream effector of Ilk in cartilage development. The use of mice overexpressing caRac1 will be useful in discovering interactions between Rac1 and various factors in vivo.
In summary, our results demonstrate that tight regulation of Rac1 activity is necessary for normal cartilage development; both reduction and increase in Rac1 activity lead to growth plate deficiencies.
